0001193125-06-149040 Sample Contracts

PHENYLBUTYRATE CO-DEVELOPMENT AND SUBLICENSE AGREEMENT BY AND AMONG BRIDGE THERAPEUTIC PRODUCTS, INC AND BRIDGE ONCOLOGY PRODUCTS, INC.
Sublicense Agreement • July 19th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations • New York

THIS AGREEMENT (the “Agreement”), is made and effective as of February 16, 2005 (the “Effective Date”), by and between Bridge Therapeutic Products Inc. (“BTP”) and Bridge Oncology Products Inc. (“BOP” and, together with BTP, the “Parties”).

Sample 1Sample 2
AutoNDA by SimpleDocs
CONFIDENTIALITY TREATMENT REQUESTED
Somanta Pharmaceuticals Inc. • July 19th, 2006 • Pharmaceutical preparations • New York

NOW THEREFORE, for good and valuable consideration, included the premises and mutual promises herein, IT IS AGREED as follows:

Sample 1
Contract
Option Agreement • July 19th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations • London

CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT IS REQUESTED AND IS NOTED WITH “[CONFIDENTIAL TREATMENT REQUESTED].” AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN PREVIOUSLY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

Sample 1
Contract
How Exclusive Sublicense Agreement • July 19th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations • California

CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT IS REQUESTED AND IS NOTED WITH “[CONFIDENTIAL TREATMENT REQUESTED].” AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN PREVIOUSLY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!